Shu Wu

About

Shu (Simon) Wu joined Legend Biotech in October 2017 as the head of the Research II Institute and ascended to the position of Vice President of Research in March 2021 before earning the title of General Manager of Greater China in August 2022. As General Manager of Greater China, Mr. Wu is responsible for operations management.

Prior to joining Legend Biotech, Mr. Wu was the Vice President of Operations for the Discovery Biology Business Unit at GenScript Inc., leading antibody therapeutics discovery and operations activities. Mr. Wu is the co-inventor of 30 patents in the field of immunotherapy and has more than 12 years of therapeutic antibody discovery and development, organizational capability building, and management experience. He has contributed to the development of successful novel discovery platforms and has led many antibody and chimeric antigen receptor T-cell (CAR-T) candidates into clinical development.

Mr. Wu received his Master of Science in Environmental Biology from the Chinese Academy of Science, China, and his Bachelor of Arts in Microbiology from Nanjing Agriculture University, China.